logo

For the Inventor, By the Inventor

Rixensart, Belgium

Smithkline Beecham Biologicals S.a.

Calculating rank
USPTO Granted Patents = 75

% Expired Patents = 37.3



Trademarks = 9

Forward Citations = 1,446

Loading Chart...
Loading Chart...

78 inventors (with patents filed for the assignee):

goldMedal Jean-Louis Ruelle (11 out of 24 patents)

silverMedal Pierre Hauser (7 out of 7 patents)

bronzeMedal Nathalie Garcon (6 out of 10 patents)

4.  Moncef Mohamed Slaoui (6 out of 11 patents)

5.  Nathalie Marie-Josephe Garcon (5 out of 14 patents)

6.  Jacques Thilly (5 out of 17 patents)

7.  Martine Anne Cecile Wettendorff (5 out of 10 patents)

8.  Joelle Thonnard (5 out of 12 patents)

9.  Martin Friede (5 out of 6 patents)

10.  Yves Lobet (4 out of 9 patents)

11.  Patricia Marie Momin (4 out of 5 patents)

12.  Pierre Desmons (4 out of 5 patents)

13.  Dirk Richard Gheysen (4 out of 8 patents)

14.  Brigitte Desiree Alberte Colau (3 out of 6 patents)

15.  Catherine Marie Ghislaine Gerard (3 out of 3 patents)


Core Competencies:
Vaccines
Adjuvants
HBV
HPV
Hepatitis
Polypeptides
Fusion Proteins
Immunogenic Compositions
Mumps Virus
Moraxella Catarrhalis
Neisseria Meningitidis
Viral Antigens

75 patents:

1. 7432366 - [object Object] (2008-10-07),
2. 7399472 - Vaccines (2008-07-15),
3. 7375091 - HER-2/neu fusion proteins (2008-05-20),
4. 7371390 - Vaccine against HBV and HPV (2008-05-13),
5. 7357936 - Adjuvant systems and vaccines (2008-04-15),
6. 7348009 - Recombinant allergen with reduced enzymatic activity (2008-03-25),
7. 7323182 - Oil in water emulsions containing saponins (2008-01-29),
8. 7285280 - Vaccine (2007-10-23),
9. 7238349 - Composition (2007-07-03),
10. 7220551 - Composition (2007-05-22),
11. 7198920 - HER-2/neu fusion proteins (2007-04-03),
12. 7192065 - System for providing communication between the interior and the exterior of a compartment (2007-03-20),
13. 7169391 - Vaccines (2007-01-30),
14. 7147862 - Vaccine composition containing adjuvants (2006-12-12),
15. 7144703 - Composition (2006-12-05),
Company Overview
Smithkline Beecham Biologicals S.a., headquartered in Rixensart, Belgium, specializes in the development and manufacture of vaccines. The organization focuses on innovative solutions to prevent infectious diseases, leveraging advanced technologies in immunogenic compositions, adjuvants, and various viral targets including hepatitis B and human papillomavirus. With a commitment to enhancing global health, the company plays a pivotal role in vaccine research and development, contributing to public health initiatives worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

75 Patents

#2 in Rixensart

#66 in Belgium

#10,029 in the World

Rixensart, BE
Rixensart, Belgium

Smithkline Beecham Biologicals S.a.

Forward Citations = 1,446

78 inventors:

goldMedal Jean-Louis Ruelle (11 out of 24 patents)

silverMedal Pierre Hauser (7 out of 7 patents)

bronzeMedal Nathalie Garcon (6 out of 10 patents)

4.  Moncef Mohamed Slaoui (6 out of 11 patents)

5.  Nathalie Marie-Josephe Garcon (5 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Smithkline Beecham Biologicals S.a.. Retrieved from https://idiyas.com/company/smithkline-beecham-biologicals-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…